LYNDHURST, N.J., May 29 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that it is scheduled to speak at the Bank
of America Healthcare Conference on Thursday, May 31, 2007, at the Four
Seasons Hotel in Las Vegas, Nevada. The Quest Diagnostics presentation is
scheduled to begin at 5:40 p.m. Eastern Time.
During the conference, the company will reiterate its 2007 guidance for
revenues of between $6.1 billion and $6.2 billion, operating income of between
16% and 17% of revenues, and earnings per diluted share from continuing
operations of between $2.75 and $2.95. These estimates exclude the impact of
the planned AmeriPath acquisition, the $0.04 per share in total first quarter
charges associated with workforce reductions and the expense of in-process
research and development, and are before charges related to potential
additional restructuring activities.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
< http://www.veracast.com/webcasts/bas/healthcare07/id03211286.cfm > and to
the public on http://www.questdiagnostics.com. In addition, the archived
webcast will be available one hour after the live presentation and will remain
available until June 15, 2007.
Quest Diagnostics is the leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive consultation through its extensive
medical and scientific staff. Quest Diagnostics is a pioneer in developing
innovative new diagnostic tests and advanced healthcare information technology
solutions that help improve patient care. Additional company information is
available at: http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2006 Form 10-K and subsequent SEC filings.
SOURCE Quest Diagnostics Incorporated
CONTACT: Investors, Laure Park, +1-201-393-5030, or Media, Gary Samuels,
+1-201-393-5700, both of Quest Diagnostics Incorporated
Web site: http://www.questdiagnostics.com